Division of Cardiothoracic Surgery, Emory University, Atlanta, Georgia.
Division of Cardiothoracic Surgery, University of Mississippi, Jackson, Mississippi.
Ann Thorac Surg. 2021 Feb;111(2):662-670. doi: 10.1016/j.athoracsur.2020.03.126. Epub 2020 May 23.
The presence of significant atrioventricular valve (AVV) regurgitation results in unfavorable conditions that affect the success of single-ventricle (SV) multistage palliation. We report our institution's AVV repair experience.
We examined incidence of AVV repair in 603 infants who underwent initial SV palliative surgery from 2002 to 2012. We explored patients' characteristics and anatomic and operative details associated with death, transplantation, and AVV reoperation.
AVV repair was performed in 60 patients during first-stage (n = 10), Glenn (n = 27), and Fontan (n = 23). Median age at AVV repair was 6.9 months (interquartile range, 4.2-24.1 months). Underlying SV anomaly was hypoplastic left heart syndrome (n = 30), heterotaxy (n = 15), and other (n = 15). The AVV was tricuspid (n = 34), mitral (n = 6), or common (n = 20). Preoperatively, all patients had AVV regurgitation moderate or higher, and 7 (12%) had ventricular dysfunction moderate or higher. After the repair, AVV regurgitation was none/trivial in 21 (35%), mild in 21 (35%), and moderate or higher in 17 (30%). Competing risks analysis showed that 10 years after AVV repair, 18% of patients had undergone AVV reoperation, 26% had died or undergone transplantation, and 56% were alive without subsequent reoperation. Transplant-free survival was 38%, 65%, and 100% for AVV repair at first-stage, Glenn, or Fontan (P = .0011), respectively, and was 74%, 83%, and 56% for tricuspid, mitral, and common AVV repair (P = .344), respectively. Factors associated with transplant-free survival were timing of AVV repair, underlying SV anomaly, and systemic ventricle function.
AVV repair at the first-stage operation and reduced systemic ventricle function are associated with poor outcomes. In those high-risk patients, different approaches that involve initial palliation mode, timing of AVV repair, or listing for transplantation might be warranted.
存在明显的房室瓣(AVV)反流会导致不利于单心室(SV)多阶段姑息治疗成功的情况。我们报告了本机构的 AVV 修复经验。
我们检查了 2002 年至 2012 年间接受初始 SV 姑息性手术的 603 名婴儿中 AVV 修复的发生率。我们探讨了与死亡、移植和 AVV 再次手术相关的患者特征、解剖和手术细节。
60 名患者在第一阶段(n=10)、Glenn(n=27)和 Fontan(n=23)手术时进行了 AVV 修复。AVV 修复的中位年龄为 6.9 个月(四分位距,4.2-24.1 个月)。SV 异常的基础疾病为左心发育不全综合征(n=30)、心脏异位(n=15)和其他(n=15)。AVV 为三尖瓣(n=34)、二尖瓣(n=6)或共同瓣(n=20)。术前所有患者均有中度或以上 AVV 反流,7(12%)例患者有中度或以上心室功能障碍。修复后,21 例(35%)AVV 反流为无/轻微,21 例(35%)为轻度,17 例(30%)为中度或以上。竞争风险分析显示,AVV 修复后 10 年,18%的患者再次接受 AVV 手术,26%的患者死亡或接受移植,56%的患者无再次手术存活。AVV 首次修复、Glenn 或 Fontan 修复的无移植生存分别为 38%、65%和 100%(P=0.0011),三尖瓣、二尖瓣和共同 AVV 修复的无移植生存分别为 74%、83%和 56%(P=0.344)。与无移植生存相关的因素包括 AVV 修复时机、SV 基础病变和左心室功能。
首次手术时进行 AVV 修复和左心室功能下降与预后不良有关。对于这些高危患者,可能需要采用不同的初始姑息治疗模式、AVV 修复时机或移植列入考虑的方法。